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ABSTRACT 
Objective: To examine the role social comparisons play in the experience of ovarian cancer 
patients and to consider the implications this may have for provision of supportive care services 
for ovarian cancer patients. 
Methods: We conducted a longitudinal qualitative study of women with advanced ovarian 
cancer in Sydney, Australia. Semi-structured interviews were conducted with women with 
advanced ovarian cancer over a period of 2.5 years. Social comparisons made by 13 study 
participants in 33 interviews were extracted and analysed using coding categories based on 
social comparison theory. 
Results: Participants favoured downward contrasts and lateral comparisons and avoided 
downward identifications, upward contrasts and upward identifications. Participants expressed 
a preference for avoiding contact with ovarian cancer patients, for the company of “normal” 
others, for normalizing information and information that facilitated upward identifications.  
Conclusions: We suggest that social comparisons made by women with ovarian cancer are 
influenced by specific clinical factors associated with their diagnosis – in particular their status as 
a member of a “vanishing cohort” – and argue for further research examining the specific 
comparison needs and preferences of patients with advanced disease and types of cancer with 
poor prognoses. 
Practice implications: These findings raise questions about uniform approaches to the provision 
of cancer care and suggest that further research may be required to ensure that interventions 
are appropriately tailored to the supportive care needs of patients with different types and 
stages of disease.  
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Introduction 
Ovarian cancer is the ninth most common cancer and the sixth most common cause of 
cancer death in Australian women. It is predicted that close to 1400 Australian women will be 
diagnosed with epithelial ovarian cancer in 2010 (approximately 0.006% of the Australian 
population) [1]. Ovarian cancer develops insidiously with no specific symptoms and as a 
consequence the majority of patients present with advanced disease (regional or distant 
metastases) [2]. Treatment of advanced disease generally requires extensive surgical resection, 
followed by multiple cycles of platinum-based chemotherapy [3]. If initial treatment is successful 
the patient may achieve a remission (no evidence of disease). Unfortunately only a small 
proportion of women experience prolonged remission or cure and the vast majority (>90%) of 
women with advanced disease will experience recurrence, on average 15 months after initial 
diagnosis [2]. Once the disease returns it is regarded as incurable, although second-line 
treatment can provide palliation and improve quality of life [4].  
Ovarian cancer patients experience a range of disease-related symptoms and treatment-
related side-effects which reduce quality of life [QoL] and psychosocial functioning, and cause 
considerable physical and psychosocial morbidity [5]. Furthermore, each woman must cope with 
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both the certainty of a poor prognosis and uncertainty about what the experience will be like for 
her and precisely how long she will survive [6]. Consequently, existential concerns, including 
difficulties with self-concept and fear of metastasis, recurrence and second cancers are common 
and significantly impact on QoL and psychosocial functioning [5]. It is hardly surprising then, that 
a number of studies have found higher than average levels of psychological distress in this group 
of patients [7,8]. However, not all women with ovarian cancer experience significant 
psychological distress [7], suggesting additional factors including psychological characteristics 
and coping strategies may mediate patient experience.  
When faced with threatening and uncertain circumstances people adopt a range of coping 
strategies. One strategy which can provide information to facilitate problem solving and assist in 
regulating emotional states [9,10], may be to compare oneself to others, a process called social 
comparison. According to social comparison theory, human beings have a drive to compare 
themselves to similar others [11], especially when faced with novel, threatening and uncertain 
circumstances [12]. Researchers have developed a typology of comparisons based on two key 
distinctions (see figure 1). Individuals may compare themselves to others whom they perceive as 
better-off (upward comparisons) or worse-off (downward comparisons) than themselves, or 
doing similarly as well (lateral comparisons) as themselves [13]. Furthermore, individuals may 
identify (overestimate similarities) or contrast (underestimate similarities) themselves with 
“others” [14,15]. These others may be “real” people or fictional individuals [14].  
 
Figure 1. Typology of Social Comparisons 
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Previous studies indicate that social comparisons have both desirable and undesirable affects 
[14]. Upward identifications may provide inspiration and hope that one will attain the same 
level as a better–off other; while upward contrasts may leave people feeling depressed that 
they are unable to attain the level of a better-off other. Downward identifications may be 
ominous and threatening because they suggest we may sink to the level of a worse-off other. 
However, contrasting ourselves with a worse-off other may allow us to feel better about 
ourselves [16,17,18]. Whether a given comparison makes us feel better or worse may be 
determined not only by our own situation and by the target of our comparison, but by a range 
of other factors, such as the degree of control we feel we have over our situation and the extent 
to which we perceive we are likely to improve or decline [14]. Despite the risk of harm 
associated with social comparisons, under certain circumstances, such as when one is faced with 
a threat to one’s health or wellbeing, particularly when that threat is associated with an 
uncertain outcome and psychological distress, the drive to compare oneself with others remains 
strong [19,20].  
Being diagnosed with cancer is an example of a novel and threatening situation which may 
strongly motivate social comparisons to similar others. Previous research has therefore used 
social comparison theory to investigate the experience of cancer patients. The results of these 
studies have generally concluded that cancer patients most frequently make downward 
contrasts, and yet they do so, where possible, without coming into direct contact with such 
worse-off others. It seems, that although making downward contrasts may allow patients to 
view their situation in a better light [9,14,21], coming into direct contact with the objects of 
these comparisons may be too frightening, presumably because such encounters provide a 
glimpse of a possible undesirable future [9,22,23,24]. Thus, patients tend to avoid direct contact 
with others who are worse-off, and instead seek direct contact with and information about 
others who share their disease (in-group others) but who are doing better than they are 
[23,25,26,27].  
Given the highly threatening and uncertain nature of ovarian cancer one would anticipate 
that social comparisons may be an important coping strategy for this group of patients. We 
report here findings from a qualitative study of patients with advanced ovarian cancer with a 
view to answering the following questions:  
1. What role do social comparisons play in the experience of a patient population with an 
extremely poor prognosis – in this case advanced ovarian cancer? 
2. How do theoretical and empirical understandings of the social comparisons made by 
unselected cancer populations translate in the context of advanced ovarian cancer? 
3. What might be the implications of these findings for the provision of supportive care 
services for patients with advanced ovarian cancer? 
 
Methods 
The dataset presented here is a subset drawn from a qualitative study of women with advanced 
ovarian cancer conducted in Sydney, Australia. The aim of the project was to investigate the 
experience of advanced ovarian cancer, with a view to informing the education of patients, 
carers and clinicians, and the organisation and delivery of care and services. A longitudinal study 
design was implemented to capture the range of experiences and often sudden changes that 
patients face throughout the natural history of ovarian cancer. Ethics approval was granted by 
Sydney West Area Health Service and the University of Sydney.  
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Sampling and recruitment 
A sequential sample of 20 women was recruited through [censored for deidentification 
purposes]. Patients were eligible for the study if they had been diagnosed with advanced (Stage 
III or IV) epithelial ovarian cancer; if they were 18-79 years of age and if they spoke enough 
English to participate in the interviews. Patients were excluded from the study if they lived 
outside Sydney’s greater metropolitan area, if they had significant psychiatric morbidity, or if 
they were unlikely to survive long enough to complete two interviews. In order to ensure the 
data was spread across the disease trajectory and thus captured the full range of patient 
experience, participants were recruited at diagnosis, first recurrence, subsequent recurrence 
and when judged to have refractory or progressive disease. 
Data collection 
Participants were interviewed at approximately four month intervals over a period of 2.5 
years or until lost to follow-up. This follow-up period was chosen to reflect the median survival 
time for patients with ovarian cancer. Upon completion of data collection 10 of the 20 
participants were deceased and 2 lost to follow-up. In the initial interview, participants were 
invited to tell the story of their illness and were asked to update their story at the beginning of 
subsequent interviews. The interviewer also drew on a list of pre-formulated questions 
regarding participants’ concerns, hopes, expectations and plans for the future and was free to 
ask spontaneous questions at any point. The interview schedule did not include questions 
designed to elicit social comparisons as the team’s research interest in social comparisons only 
emerged during the later stages of the project. At the end of each interview the participants 
completed questionnaires including socio-demographic factors, quality-of-life measures (FACT–
O and HADS) and additional indicators of psycho-social support, including whether participants 
had a spouse/partner and/or carer, were taking medication or receiving therapy for mental 
health issues, or had attended a support group. The interviews were digitally recorded, 
transcribed and anonymised.  
Inductive Coding and Analysis 
Analysis of the interviews was inductive and informed by Morse’s description of the 
generic cognitive underpinnings of qualitative research [28]. As the interviews were completed, 
members of the research team read the interviews and identified emergent themes warranting 
further in-depth analysis. These themes were then abstracted into categories and concepts and 
coded using code-and-retrieve software.   
 
A Study of Social Comparisons in Advanced Ovarian Cancer 
As data collection and recruitment progressed we observed that all participants recruited thus 
far had been utilising social comparisons. We therefore decide to systematically re-analyse 
(reread) all interviews that had been conducted to date for social comparisons.  
 
Dataset 
At the time of analysis 13 participants had been recruited. All 13 participants had been treated 
with extensive abdominal surgery and platinum-based chemotherapy after initial diagnosis. 
Those with recurrent disease (9) were treated with further chemotherapy. Treatment ceased (2) 
when patients were no longer well enough to tolerate chemotherapy (1) or when their cancer 
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was judged to be chemotherapy resistant (1). The median age at diagnosis was 51 years (range 
37-68 years). Interviews with all 13 participants were ongoing at the time our interest in social 
comparisons arose and we chose to only include those interviews conducted prior to 
commencement of the social comparison analysis. The dataset thus contained a total of 33 
interviews, with an average of 2.5 per participant (range 1 to 4). All phases of the cancer 
continuum were captured by the dataset. For further information about participants and timing 
of interviews see Tables 1 and 2.  Thematic saturation was reached on the basis of the 33 
interviews included in this initial sample and therefore later interviews with these 13 
participants and from the 7 participants subsequently recruited were not incorporated into the 
social comparison analysis. 
 
Table 1. Characteristics of Participants 
Characteristics of participants 
Stage of disease 
Stage III Stage IV 
10 3 
Disease point at recruitment 
Diagnosis 
1st 
Recurrence 
Subsequent 
recurrence/ 
refractory 
7 3 3 
Ethnic background 
Anglo-
Australian 
UK 
Non-English 
speaking 
7 3 3 
Employment status 
Unemployed Employed 
5 8 
Children 0 1 2 3 4 5 
(average 2.6) 3 1 4 4 0 1 
 
Table 2. Characteristics of Interviews 
Characteristics of interviews 
Disease point of 
interview 
Initial 
diagnosis 
1st 
Remission 
1st Recurrence 
Subsequent 
Remission 
Subsequent 
Recurrence 
Refractory/ 
progressive 
disease 
5 8 8 3 3 6 
Treatment 
status at time of 
interview 
Undergoing treatment Not undergoing treatment 
18 15 
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Deductive Coding and Analysis  
Coding categories for the analysis were based on the typology of upward/downward/lateral and 
identifying/contrasting described in the existing social comparison literature, as well as the type 
of comparison target. The interviews were examined for social comparisons and coded using a 
code-and-retrieve software program with a view to answering the following specific questions: 
1. Did social comparisons occur, unprompted, in the interviews? 
2. What types of comparisons were made? 
3. What were the affective consequences of the different comparison types? 
4. What were the most common types of comparison made? 
5. Did the participants display preferences for avoiding interaction with worse-off others 
and for contact with those faring better? 
6. Did participants display a preference for information regarding those faring better? 
7. Did participants show a preference for making comparisons to other ovarian cancer 
patients? 
8. Did participants compare themselves with ‘real’ or ’fictional’ others? 
Initially the coding exercise was practiced by both qualitative researchers on the team (BM and 
CJ). Coding of social comparisons was compared and discussed in order to clarify any areas of 
nonconcordance, until it was deemed that social comparisons were being identified and coded 
in a consistent manner and in accordance with the research questions. Once this consistency 
had been established the first author (BM) continued the coding exercise independently. The 
results of this analysis were then presented to the entire team for discussion and final decision-
making. 
 
Results 
 
Frequency and Affects of Comparison Types  
 
All comparison types occurred frequently and without prompting in participants’ talk. 
Consistent with other studies of cancer populations, downward contrasts were the most 
common comparison type made by the participants (33.4%)1(see Table 1) and were the 
preferred comparison type for 38% of participants. Somewhat surprisingly, given their latency in 
the literature, lateral comparisons were also very common (31.1%) and were the preferred 
comparison type for 46% of participants. Lateral comparisons were also the only comparison 
type used by all participants. Also surprising given the results of previous studies, upward 
identifications were the most infrequent comparison type (5.9%), followed by downward 
identifications (8.8%) and upward contrasts (16.8%).  
 
 
                                                 
1
 Percentages were calculated by dividing the total number of a specific comparison type by the total 
number of social comparisons. 
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Table 3. Frequency of Comparison Types 
 Comparison Direction 
Downward Lateral Upward 
Nature of 
Comparison 
Identifying 8.8%  
(range 0-37%) 31.1% 
(range 9.5-62.5%) 
5.9% 
(range 0-15.2%) 
Contrasting 33.4% 
(range 0-75%) 
16.8% 
(range 0-52%) 
 Total 42.2% 31.1% 22.7% 
 
The affects associated with each of the comparison types were largely as reported 
previously in the social comparison literature. Upward identifications were inspiring and 
hopeful.  
That nurse, you wouldn’t think she was in the same boat as I am, she goes, “For eleven 
years now, I’m still fighting, I’m still working”, things like that you hear are very 
inspirational. 
Upward contrasts had a deflating effect on participants and often involved negative evaluations 
of their own coping: 
After the second recurrence I’m shaken … I don’t know whether one can really prevent 
it from happening, and then I think about people … who’s getting much more years and 
I think, do they do something different? 
Downward contrasts were used to enhance participants’ sense of self and were frequently used 
to frame the participant as “the lucky one”, contributing to optimistic and even exceptional 
predictions of prognosis 
I was saying how lucky I’d been because I know a couple of other ladies who’re really 
sick with the treatment, one of them has since passed away, but she couldn’t tolerate 
the treatment and I’ve been so fortunate.  
Consistent with results of previous studies, downward identifications were the most frightening, 
anxiety provoking comparisons, often indicating threatening predictions for the future: 
My sister died, and I don’t think I was ready to take it. I look in the mirror and I look like 
her. That’s enough on its own. She’s not here anymore. What frightens me most is I 
know what it’s going to be like at the other end. That’s really scary. 
Lateral comparisons, in which participants identified or contrasted themselves with others who 
were no better or worse off than themselves, functioned to normalize experience, particularly in 
relation to the symptoms and side-effects of the disease and treatment: 
Reading that form made me realize, ‘This is a normal thing’, going to chemotherapy, 
hear people talking, I think, ‘Has that happened to her? It happens to me.’ It’s normal 
again. A lot of things are turning out to be normal. 
At times these lateral comparisons were used to mitigate the portentousness of severe or 
unique symptoms or test results: 
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When she was first diagnosed I think her CA1252 was only about 400, whereas mine was 
2900 … I think we’re all unique in that regard, so I’m hoping that although I have a very 
high count my body reacts like, ‘Oh it’s here, woah!’ … I don’t know, I think maybe my 
number goes up very high. 
An examination of comparisons types made at different time points (interview number 
and clinical status) found no significant changes. Participants continued to draw from the range 
of comparison types and targets throughout their participation in the study. 
 
Contact and Information Preferences  
Previous research suggests that cancer patients will seek contact with others who share 
their disease (in-group others) but will prefer that such contact involves others who are better-
off than themselves (see above). Indeed, a few participants in this study did speak of the 
desirability of contact with in-group others due to the opportunity it provided for understanding 
and normalizing their experience. However, while all 13 participants in our study were invited to 
attend a disease-specific support group as part of the standard care provided by their specialist 
unit, 8 had never attended. Of the remaining 5, 3 ceased attendance after one or more sessions 
and only 1 was a regular attendee. Participants were not routinely questioned about these 
decisions. However, throughout the course of the interviews a clear preference emerged for 
avoiding contact with all in-group others, whether faring better or worse than themselves, 
because such encounters held the potential for providing them with frightening examples of 
worse-off others with whom they might identify. When asked whether she had found the 
support group helpful one participant explained that: 
It can scare you when you talk to people. They say, “I went and took this treatment, 
then I got it again”. It can negatively affect you. So it’s not good, unless you hear positive 
stories which most of the time is not the case when you go to the support group. Of 
course some people are there, but then you hear from someone and that can really 
shake you. … The effect [the good news] has on you can be overridden by someone’s 
negative experience. 
Instead, participants most frequently sought fun and distraction through interactions with what 
they considered to be “normal” others, that is, out-group others. Such interactions avoided the 
painful reminders of their disease and reinforced the speaker’s identity as “normal” person 
rather than as a cancer patient. 
When I feel well and I’m out with my friends I’m just me, I’m not someone living with 
cancer … I think a healthier thing for me is to be around normal, healthy, positive, all the 
good things in life, not sitting around, ‘We’ve all got something in common: ovarian 
cancer. Isn’t that great?’ 
When it came to information, participants, as in previous studies of cancer patients, 
expressed a clear desire for information about others who were faring better than themselves. 
In particular, they commented on the hope they were able to gain from stories of survivors who 
had beaten the odds, and the guidance this gave them in attempting to follow this path. 
                                                 
2
 The tumour marker, or CA125, referred to is used as an indicator of the presence and, at times, the 
severity of disease. However, as this participant is indicating, individuals vary greatly in the extent to which 
their ‘number’ increases or decreases in response to disease and therefore a significantly higher CA125 
reading may not mean that the individual has more severe disease than a patient with a lower reading. 
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I’ve been reading about people who are survivors, where the doctors have given up 
hope and told them to go home because they can’t treat them but those people have 
survived. Of course they’ve done a lot of other things in their life. So at this point I’m 
trying to think that I must do much more than being complacent. 
Information that normalized symptoms and side-effects, as well as emotional responses to 
cancer, was also considered desirable. 
I’ve been talking to the clinical psychologist about survivorship, about feelings of guilt. 
I’ve talked to the social worker because this is quite normal … 
However, general statistical information about ovarian cancer patients was unanimously 
regarded as depressing and frightening and participants often spoke of deliberately not reading 
such information. 
In the newspapers they wrote about what I had … I fell to pieces for quite awhile over 
this, “1,000 people in this area are going to get ovarian cancer this year, out of that 
1,000 people 800 are going to die” … I won’t read a newspaper anymore … That was just 
wrong. If they want to write about it do it in a nice way, not to scare people … Some 
people could give up hope reading that. I did. 
 
Choice of Comparison Others 
Less than half (39%) of the observed comparisons involved in-group others. In other 
words, participants frequently chose to compare themselves with patients who had other forms 
of cancer that differ considerably from ovarian cancer in terms of symptoms, treatment and 
prognosis (such as breast cancer). They also frequently chose to compare themselves to patients 
with illnesses other than cancer, and to healthy others such as family and friends.  
Overall, the majority of comparisons did not involve tangible others with whom 
participants had actual contact or about whom they have received information. Rather, the 
majority of comparisons involved fictional or hypothetical others (62%)(see Table 2) including 
hypothetical ovarian cancer patients or chemotherapy patients and references to very 
generalized groups such as ‘other cancer patients’ and often simply ‘other people’. This 
tendency was particularly strong for downward contrasts (72%).  
 
Table 4. Choice of Comparison Others 
 Comparison Other 
Real Fictional/Hypothetical 
Comparison 
Type 
Downward identification 70% 30% 
Downward contrast 28% 72% 
Lateral comparison 39% 61% 
Upward identification 53.3% 46.7% 
Upward contrast 37% 63% 
 Total 38% 62% 
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Discussion and conclusion 
Discussion 
Our results are consistent with research indicating that social comparisons are commonly 
made by cancer patients, that these comparisons vary in type and target, that they confer both 
subjective benefits and harms of the kind described by social comparison theory and that cancer 
patients favour downward contrasts and prefer to avoid downward identifications and upward 
contrasts. Participants’ choice of fictional/hypothetical others for the majority of their 
downward contrasts and their desire for inspiring information is also consistent with research 
suggesting that while they may wish to make downward contrasts, cancer patients will generally 
avoid direct contact with and information regarding worse-off others [9,16,22,23,24].  
A number of our results however, did not align with previous theoretical and empirical 
work and thus warrant further discussion. Upward identifications, despite generating positive 
affect, were expressed least frequently. Lateral comparisons, which have received little 
attention in empirical studies of cancer patients, were made almost as frequently as downward 
contrasts and were the only comparison type made by all participants. Furthermore, unlike 
those in other studies, our participants made most of their comparisons to others who did not 
share their disease (out-group others). Finally, and perhaps most importantly, a clear majority of 
participants in this research did not seek contact with other patients with ovarian cancer but 
instead expressed a preference for avoiding such encounters. This was captured by their 
aversion to support group attendance and the apparent appeal held by the company of 
“normal” others. Although previous research has indicated a tendency for cancer patients to 
avoid direct contact with others who are worse-off than themselves, a preference for avoiding 
all contact with in-group others has not previously been reported and stands in opposition to 
something of the accepted wisdom regarding the benefits of peer support for cancer patients. 
We suggest that social comparison needs and preferences may differ according to type 
and stage of disease [29,30]. In particular, we would argue that specific “clinical” characteristics 
of one’s disease, such as natural history, life-time risk, prognosis, mortality rate and average five 
year survival, alter the balance of risks and benefits associated with in-group comparisons and 
consequently the type and target of comparisons one will favour. Consequently, patients with 
advanced disease or poor/terminal prognoses – those who belong to what we have termed a 
“vanishing cohort” (a cohort in which a bad outcome is almost a certainty) - may evidence 
particular patterns of social comparison preferences. The possible variability of comparison 
needs and preferences across cancer populations is not something that has been adequately 
captured by previous research as the majority of social comparison studies have not sought to 
distinguish their participants by type or stage of disease or have been weighted toward the 
views of those with early stage disease or good prognoses. Previous studies have commonly 
included participants with a range of cancer types [10,14,23,26,27,29,30,31,32] and have either 
included a range of disease stages [14,25,26] or have not reported the disease stage of their 
participants [9,14,25,26]. Studies that have focused on more specific patient populations have 
predominantly or exclusively included those with early stage disease [22,24,33,34], those with a 
good prognosis [14,26] or patients who were no longer under active treatment [23,27,35,31] or 
have excluded patients who were thought to have less than twelve months to live [10,30,32]. 
This study, therefore, provides information about a specific and understudied population – 
women with advanced disease from a cohort with a poor prognosis.  
 Furthermore, as a number of theorists have argued, it is important to strengthen the 
results of conventional fixed-response studies by capturing the comparison preferences of 
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patients in more naturalistic settings [22,27,33] – an approach exemplified by studies 
incorporating Ecological Momentary Assessment [36,37]. In their use of fixed response methods, 
the majority of studies of social comparisons amongst cancer patients have limited the 
comparison preferences participants were able to report – frequently by excluding out-group 
comparisons and/or lateral comparisons – and thus the pattern of comparison needs and 
preferences that emerged. However, participants in our study were free to make as many or as 
few comparisons as they desired and to shape these comparisons to meet their needs and 
preferences. Participants were able to express comparisons to and preferences for contact with 
whomsoever they chose, be they in-group or out-group others, and others doing better, worse 
or similarly as well as themselves. Thus, we were able to gain more in-depth insight into ovarian 
cancer patients’ comparison needs and preferences.  
 Due to the qualitative nature of our data, drawn as it is from interviews with a small 
number of participants, our results are not generalisable to a wider population and remain 
tentative. The nature of our study also precludes us from presenting any insights into whether 
the types of comparisons participants made varied according to individual demographic and 
psychosocial characteristics or how social comparisons change with disease progression. 
Importantly, as this study describes a specific cancer population our results need confirmation in 
studies involving larger numbers of participants and in different populations of cancer patients. 
While our results provide an important contribution to existing research as they capture the 
experiences of an understudied population and illuminate the ways in which patients’ 
comparison needs and preferences may vary according to the types and stages of disease, they 
demonstrate also that further research is needed into the social comparisons made by patients 
with cancer and with serious and terminal illness. This research should not simply reproduce 
existing methods but should include understudied cancer populations; should adopt longitudinal 
designs in order to track comparisons across the disease trajectory; and should go beyond 
conventional fixed response methods and laboratory studies by utilising free response methods 
and ethnographic approaches, and thus take into account an unlimited range of comparison 
types and targets thereby allowing the full range of needs and preferences of different cancer 
populations to emerge. 
 
Practice Implications 
The importance of supportive care for patients with cancer has been clearly demonstrated 
(for a review see [16]), however much work remains in identifying and implementing the most 
effective forms of care. In recent years disease-specific support groups have, whether out of 
preference or necessity, become the predominant, and at some health facilities the only, form 
of supportive care provided to cancer patients [38]. These groups are convened on the premise 
that interactions with “similar others” may benefit patients by providing them with an 
opportunity to share common experiences and thereby find mutual support and understanding 
(see for example, [38]; [39]). The opportunity to make social comparisons has also been touted 
as one of the many benefits of these groups [40]. Evidence that disease-specific support groups 
benefit cancer patients is considerable and although some studies have indicated that the 
support group environment may not be suitable for all cancer patients [41], in both the 
empirical and theoretical literature, there is an overriding assumption that increasing 
attendance at support groups is a good thing [42]. However, research examining the benefits of 
such groups has been heavily weighted towards the experiences of patients with early stage 
disease and patients who choose to attend the groups [43,39,44,45,46]. The study reported 
here thus adds to the existing literature on supportive care in cancer in two important ways. 
 13 
First, it adds to research examining the experiences of patients with advanced disease, and so 
assists in illuminating the limits at which disease-specific support groups can be assumed to be 
of benefit to cancer patients. Second, it examines the experiences of a group of patients who 
predominantly chose not to attend a group, and whose lack of attendance can not be explained 
by lack of awareness or availability of such groups. 
While this study is consistent with previous research indicating that social comparisons 
can be of benefit to the psychosocial wellbeing of cancer patients and that, therefore, 
facilitating these comparisons should be a central consideration in the provision of supportive 
care, our results also suggest that for patients with different types and stages of disease, the 
risks and benefits of social comparisons may differ, and consequently so may the benefits and 
harms of different forms of supportive care. We suggest that a tailored approach to supportive 
care in cancer, that takes into account the specific characteristics and experiences of each 
disease group, may be necessary. In particular we would argue, that it is important to take 
seriously the contention that some groups of patients may not benefit from and may even be 
harmed by participation in disease-specific support groups, that a uniform approach to 
supportive care in cancer is not satisfactory and that alternative forms of care ought to be made 
available [47,48,49,50]. Disease-specific support groups clearly benefit many patients by 
facilitating positive social comparisons, and the growth of these groups has certainly been of 
benefit to the cancer community. However, we believe further research is needed to establish 
which groups of patients benefit most from disease-specific support groups and how supportive 
care interventions can be tailored to the supportive care needs of patients with different types 
and stages of disease.  
While further research will be necessary to establish which forms of supportive care will be of 
greatest benefit for ovarian cancer patients, on the basis of this study we would suggest that 
appropriate services are likely to be those that facilitate normalising lateral comparisons, whilst 
at the same time avoiding the harms associated with comparisons to better- or worse-off in-
group others. In other words, for ovarian cancer patients supportive care interventions that 
provide interactions with and information regarding others who are doing similarly as well, 
rather than seeking to provide patients with better-off ‘inspirational’ in-group others may be of 
most benefit. Interventions such as one-to-one psychosocial care; provision of comparison 
information that is appropriately tailored to specific phases of the disease trajectory; facilitation 
of contact between patients who are at similar stages in the disease trajectory (i.e. recently 
diagnosed, remission, recurrence, progressive/refractory disease); online patient networks and 
peer support groups that are convened on the basis of commonalities other than diagnostic 
category and which may provide opportunities to make social comparisons on a less threatening 
pretext [43], would usefully be the subject of future research. Furthermore, we feel that it 
would be inappropriate on the basis of this study to exclude the possibility that for some ovarian 
cancer patients disease-specific support groups may be beneficial. However, further research is 
needed to assist in identifying which individuals may benefit from these groups and to establish 
methods for recruiting and maintaining such groups in order to maximise their benefits for 
patients. Ultimately, health professionals involved in cancer care will need to consider the role 
that they play and the role that the design and delivery of care services plays in mediating the 
experience of patients with advanced ovarian cancer and the comparisons that each woman will 
make along her cancer trajectory [51].  
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Conclusion 
 
The experience of ovarian cancer is characterized by the dynamic interplay of both 
certainty and uncertainty, and patients’ efforts to adapt to extreme circumstances can be both 
helped and hindered by social comparisons with similar others. The findings presented here 
suggest that further research may be required to understand the ways in which comparison 
needs and preferences may vary for cancer patients with different types and stages of disease 
and to ensure that psycho-social interventions are appropriately tailored to the supportive care 
needs of individual patients.  
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